• KGS/USD = 0.01144 0%
  • KZT/USD = 0.00198 0%
  • TJS/USD = 0.10695 0.66%
  • UZS/USD = 0.00008 0%
  • TMT/USD = 0.28490 -0.28%
  • KGS/USD = 0.01144 0%
  • KZT/USD = 0.00198 0%
  • TJS/USD = 0.10695 0.66%
  • UZS/USD = 0.00008 0%
  • TMT/USD = 0.28490 -0.28%
  • KGS/USD = 0.01144 0%
  • KZT/USD = 0.00198 0%
  • TJS/USD = 0.10695 0.66%
  • UZS/USD = 0.00008 0%
  • TMT/USD = 0.28490 -0.28%
  • KGS/USD = 0.01144 0%
  • KZT/USD = 0.00198 0%
  • TJS/USD = 0.10695 0.66%
  • UZS/USD = 0.00008 0%
  • TMT/USD = 0.28490 -0.28%
  • KGS/USD = 0.01144 0%
  • KZT/USD = 0.00198 0%
  • TJS/USD = 0.10695 0.66%
  • UZS/USD = 0.00008 0%
  • TMT/USD = 0.28490 -0.28%
  • KGS/USD = 0.01144 0%
  • KZT/USD = 0.00198 0%
  • TJS/USD = 0.10695 0.66%
  • UZS/USD = 0.00008 0%
  • TMT/USD = 0.28490 -0.28%
  • KGS/USD = 0.01144 0%
  • KZT/USD = 0.00198 0%
  • TJS/USD = 0.10695 0.66%
  • UZS/USD = 0.00008 0%
  • TMT/USD = 0.28490 -0.28%
  • KGS/USD = 0.01144 0%
  • KZT/USD = 0.00198 0%
  • TJS/USD = 0.10695 0.66%
  • UZS/USD = 0.00008 0%
  • TMT/USD = 0.28490 -0.28%
02 February 2026

Our People > Sergey Kwan

Sergey Kwan's Avatar

Sergey Kwan

Journalist

Sergey Kwan has worked for The Times of Central Asia as a journalist, translator and editor since its foundation in March 1999. Prior to this, from 1996-1997, he worked as a translator at The Kyrgyzstan Chronicle, and from 1997-1999, as a translator at The Central Asian Post.
divider
Kwan studied at the Bishkek Polytechnic Institute from 1990-1994, before completing his training in print journalism in Denmark.

Articles

Kyrgyzstan and China to Launch Direct Flight Between Osh and Kashgar

A new air route connecting Osh, Kyrgyzstan’s second-largest city, with Kashgar in China’s Xinjiang Uyghur Autonomous Region is expected to launch in April, according to a statement from Airports of Kyrgyzstan JSC. The announcement follows a meeting held on January 30 with the Commercial Aircraft Corporation of China (COMAC). The new flight is intended to enhance transport connectivity between the two neighboring countries, deepen bilateral trade and economic ties, and promote tourism and cultural exchange. The route is expected to be operated by Chengdu Airlines, a COMAC-affiliated carrier, using COMAC’s C919 aircraft, China’s first domestically developed short-to-medium-range turbofan jet, which can accommodate up to 97 passengers. Osh already has an existing air link to Xinjiang. In November 2025, China Southern Airlines resumed flights between Osh and Urumqi, the region's capital. Xinjiang serves as a strategic gateway to China for Kyrgyzstan, and Kashgar is the departure point for the China-Kyrgyzstan-Uzbekistan (CKU) railway, an ambitious regional infrastructure project aimed at connecting China with Central Asia, the Middle East, and Europe. The 523-kilometer railway will run from Kashgar to Andijan, Uzbekistan, passing through Kyrgyzstan via Torugart, Makmal, and Jalal-Abad. Construction on the CKU railway officially began on December 27, 2024, in Kyrgyzstan’s Jalal-Abad region. New transport links by air and rail are expected to further boost trade between Kyrgyzstan and China. According to Chinese Ambassador to Kyrgyzstan Liu Jiangping, bilateral trade reached a record $27.2 billion in 2025, up 20% from the previous year.

9 hours ago

Kyrgyzstan Suspends Private Driving Schools in Bid to Improve Road Safety

Kyrgyzstan has temporarily suspended the operations of all private driving schools as part of a sweeping reform aimed at improving driver education and road safety. On January 29, President Sadyr Japarov signed a decree introducing a trial period, effective until August 30, 2026, during which driver training will be conducted exclusively through state-run driving schools.  The reform also mandates a significant extension of the training period from the current 2.5 months to 10 months. Authorities say the new measures are designed to reduce traffic accidents and eliminate corruption in the issuance of driver's licenses. As of 2025, Kyrgyzstan had 340 driving schools, including 74 state-run institutions and 266 privately operated ones. Officials cite systemic issues in the private sector, including substandard instruction, widespread corruption, and the illegal sale of licenses. Daiyrbek Orunbekov, Head of the Information Policy Service under the Presidential Administration, addressed public concerns over the extended training period in a Facebook post on January 29.  He emphasized that the 10-month program is intended solely to improve driver competence and reduce accidents. “A driver who has acquired sufficient knowledge poses no danger to themselves, passengers, or other road users,” Orunbekov wrote. Under the new model, instruction will include both theoretical and practical training held two to three times per week, with each session lasting two to three hours. Some classes may be offered online. The curriculum will also cover psychological preparation and road ethics. In response to critics who argue that the current 2.5-month course is adequate, Orunbekov said that meaningful learning cannot occur in such a short timeframe. He cited international practices, noting that in many developed countries, driver training takes significantly longer. In Finland, the process can last up to a year and includes a probationary license period; in Germany, it ranges from six to twelve months; in Sweden and Norway, up to a year; and in the United Kingdom, Canada, the U.S., Australia, and New Zealand, it can take up to two years. The reform follows concerning national road safety data. In 2025 alone, Kyrgyzstan recorded 8,456 traffic accidents, resulting in 900 deaths and 12,169 injuries. Over the past decade, more than 75,000 accidents have claimed over 9,000 lives. According to Orunbekov, many current drivers lack even basic knowledge of traffic regulations and, in some cases, cannot recall where they were trained. He described this as a lingering consequence of a flawed and often corrupt driver education system.

3 days ago

Kyrgyzstan Bans Animal Imports from India to Prevent Nipah Virus Spread

On January 28, Kyrgyzstan’s Veterinary Service imposed temporary restrictions on the import of live animals and animal products from India in response to confirmed cases of Nipah virus infections. According to the World Health Organization (WHO), Nipah virus is a severe zoonotic disease transmitted to humans through contact with infected animals, such as fruit bats or pigs, or through consumption of food contaminated by bat secretions. Human-to-human transmission is also possible through close contact. The virus has an estimated case-fatality rate of 40% to 75%. Two confirmed cases of Nipah virus were reported in late December in India’s eastern state of West Bengal. Both infected individuals were healthcare workers. Following these reports, authorities in Thailand, Singapore, Hong Kong, and Malaysia intensified airport screenings to contain the risk of cross-border transmission. Kyrgyzstan’s Ministry of Health has issued a statement urging the public to remain calm, noting that no cases of Nipah virus have been registered in the country. The ministry assured that the healthcare system is prepared to respond swiftly to potential epidemiological threats. As a preventive measure, sanitary and quarantine controls have been tightened at Kyrgyzstan’s border crossings. The ministry continues to collaborate with the WHO and other international partners to monitor developments and coordinate containment efforts. In neighboring Kazakhstan, the Ministry of Health issued a similar statement confirming that no cases of Nipah virus infection have been detected and that the epidemiological situation remains under control. As a precaution, Kazakhstan has also enhanced screening procedures at all border checkpoints, with special attention to travelers arriving from India and Southeast Asia.

4 days ago

Kazakhstan-Uzbekistan Jibek Joly Train Tour Extended to Tajikistan

Kazakhstan’s national railway company, Kazakhstan Temir Zholy (KTZ), has announced the expansion of its popular Jibek Joly (Silk Road) tourist train route to include Tajikistan, adding a new stop to one of Central Asia’s flagship railway tourism initiatives. The updated route will now reach the Tajik capital, Dushanbe, extending the tour beyond Kazakhstan and Uzbekistan for the first time. The inaugural journey on the extended route is scheduled to depart from Almaty on March 20, 2026, and return on March 25, passing through a series of historic Silk Road cities: Turkestan (Kazakhstan), Samarkand (Uzbekistan), Dushanbe (Tajikistan) and Tashkent (Uzbekistan). The tour package includes rail travel, guided sightseeing, entrance to cultural and historical sites, and organized transfers. Its launch coincides with Nauryz, the region’s traditional spring holiday, allowing travelers to experience vibrant local celebrations along the way. First introduced in November 2024, the Jibek Joly train originally ran between Almaty, Turkestan, and Tashkent, and has since become a highly visible symbol of the region’s growing tourism sector. The project reflects broader efforts to promote Central Asia as a unified tourist destination. Regional leaders have advocated for a shared visa-free regime for foreign visitors, similar to Europe’s Schengen Zone, to encourage cross-border travel and boost international tourism. Officials say that initiatives like Jibek Joly can help strengthen cultural ties, foster regional integration, and raise Central Asia’s profile on the global tourism map.

5 days ago

Kazakh Science Ministry Expands Strategic Partnership with AstraZeneca

Kazakhstan has entered a new phase of cooperation with British-Swedish pharmaceutical giant AstraZeneca, expanding the partnership beyond healthcare into science, education, and innovation. On January 26, Minister of Science and Higher Education Sayasat Nurbek visited AstraZeneca’s Discovery Centre in Cambridge, the company’s largest global research and innovation hub, where a memorandum of understanding was signed with AstraZeneca Kazakhstan. According to the ministry, the agreement paves the way for new areas of collaboration aimed at strengthening national scientific capacity, introducing advanced medical technologies, and enhancing the long-term sustainability of Kazakhstan’s healthcare system. The partnership will focus on several strategic areas: Real-World Data (RWD) and Real-World Evidence (RWE): Development of advanced data analytics tools to support scientific research, clinical decision-making, and evidence-based healthcare policy. Expansion of the Young Health Program: Prevention of non-communicable diseases among youth and the promotion of responsible health behaviors. Sustainable Development and Economic Diversification: Joint initiatives in environmental protection, green technologies, and sustainable business practices. Early Diagnosis and Healthcare Resilience: Implementation of modern screening methods, specialist training, and development of diagnostic infrastructure. Nurbek highlighted that the memorandum creates new opportunities to integrate research, education, and real-world clinical practice. “It is important not only to develop fundamental science, but also to ensure the transfer of advanced technologies and data into everyday medical practice. This partnership strengthens Kazakhstan’s scientific and biomedical potential,” he said. AstraZeneca has steadily expanded its operations in Kazakhstan in recent years. In April 2024, the Ministry of Healthcare, the Almaty city administration, national investment agency Kazakh Invest, and AstraZeneca signed an agreement on the contract manufacturing of biotechnological products. The initiative supports Kazakhstan’s strategic goal of increasing the share of domestically produced medicines to 50%. In July 2024, AstraZeneca and the state pharmaceutical distributor SK-Pharmacy signed a long-term agreement on local production and technology transfer. According to Maria Shipuleva, CEO of AstraZeneca Kazakhstan, the company’s innovative medicines will be produced at the Nobel Almaty Pharmaceutical Factory. The production portfolio includes treatments for diabetes, chronic heart failure, chronic kidney disease, multiple forms of leukemia, and cancer therapies for breast, ovarian, prostate, and pancreatic cancers.

6 days ago